Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Massachusetts General Hospital
University of California, San Francisco